SBC Medical Group (NASDAQ:SBC – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.
Volatility & Risk
SBC Medical Group has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Precipio has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500.
Valuation and Earnings
This table compares SBC Medical Group and Precipio”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SBC Medical Group | $173.61 million | 3.13 | $50.99 million | $0.47 | 11.23 |
| Precipio | $24.05 million | 1.35 | -$360,000.00 | ($0.64) | -28.28 |
SBC Medical Group has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and target prices for SBC Medical Group and Precipio, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SBC Medical Group | 0 | 1 | 2 | 0 | 2.67 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
SBC Medical Group presently has a consensus price target of $8.50, indicating a potential upside of 60.98%. Given SBC Medical Group’s stronger consensus rating and higher possible upside, equities research analysts plainly believe SBC Medical Group is more favorable than Precipio.
Insider & Institutional Ownership
60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 10.4% of Precipio shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 16.6% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares SBC Medical Group and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SBC Medical Group | 27.99% | 18.47% | 13.10% |
| Precipio | -4.47% | -8.49% | -5.75% |
Summary
SBC Medical Group beats Precipio on 13 of the 14 factors compared between the two stocks.
About SBC Medical Group
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
